<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Weil, Irmgard Progress Note</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Weil, Irmgard Progress Note</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">MS Irmgard Weil</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">January 7, 1938 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Unknown</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Unknown</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Primary Home Address:<br/>232 Comanche Court<br/>Henderson, NV 89074<br/><br/>Primary Home Phone:  (702)521-3166<br/>Mobile Phone:  (702)461-7687<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">141218 2.16.840.1.113883.3.623<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">ProgressNote_Weil_20240812_1203_06.271 2.16.840.1.113883.3.623</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">August 12, 2024, 12:03:06, MST </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Ammar Yousif of The Oncology Institute of Hope and Innovation</td></tr><tr><td class="td_header_role_value internal_format"><br/><br/><br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">G2Carequality Interface, The Oncology Institute of Hope and Innovation</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">Arizona, California, Florida<br/>Downey, CA 90241<br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">9937012 2.16.840.1.113883.19</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">PHYS/QHP TELEPHONE EVALUATION 5-10 MIN</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From July 8, 2024  to July 8, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value"/></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Informant</span></td><td class="td_header_role_value">Ammar Yousif of The Oncology Institute of Hope and Innovation</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">McKesson Specialty Health</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">10101 Woodloch Forest<br/>The Woodlands, TX 77380, USA<br/><br/>Work Phone:  800 381 2637<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Assessment</a></li><li><a href="#id2">Allergies and Adverse Reactions</a></li><li><a href="#id3">Plan</a></li><li><a href="#id4">Reason for Visit</a></li><li><a href="#id5">Encounters</a></li><li><a href="#id6">Immunizations</a></li><li><a href="#id7">Diagnostic Results</a></li><li><a href="#id8">Medications</a></li><li><a href="#id9">Problems</a></li><li><a href="#id10">Vital Signs</a></li><li><a href="#id11">Notes Section</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Assessment</a></h3><div>See Clinical Notes section</div><h3><a name="id2" href="#toc">Allergies and Adverse Reactions</a></h3><div><table>
    <thead>
        <tr>
                            <th>Medication/Group Name</th>
                <th>Reaction</th>
                <th>Severity</th>
                <th>Date</th>
        </tr>
    </thead>
    <tbody>
                <tr ID="AlertOBS-1000">
                            <td>etodolac</td>
                            <td>Vertigo</td>
                            <td>Moderate</td>
                            <td>08/07/2024</td>
                </tr>
                <tr ID="AlertOBS-1001">
                            <td>acetazolamide</td>
                            <td>Rash</td>
                            <td>Moderate to severe</td>
                            <td>08/07/2024</td>
                </tr>
                <tr ID="AlertOBS-1002">
                            <td>morphine</td>
                            <td>Cough</td>
                            <td>Moderate to severe</td>
                            <td>08/07/2024</td>
                </tr>
                <tr ID="AlertOBS-1003">
                            <td>Sulfamide</td>
                            <td>Unknown</td>
                            <td>Moderate to severe</td>
                            <td>08/07/2024</td>
                </tr>
                <tr ID="AlertOBS-1004">
                            <td>codeine</td>
                            <td>Diarrhea</td>
                            <td>Moderate</td>
                            <td>08/07/2024</td>
                </tr>
    </tbody>
</table>
</div><h3><a name="id3" href="#toc">Plan</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="CarePlanRef-1005">
						<td>07/08/2024</td>
						<td>APPOINTMENT</td>
						<td>TELEPHONIC F/U</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id4" href="#toc">Reason for Visit</a></h3><div>FOLLOW UP</div><h3><a name="id5" href="#toc">Encounters</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="EncounterDiagnosisRef-1006">
							<td>07/08/2024</td>
							<td>Anemia</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1007">
							<td>07/08/2024</td>
							<td>Breast cancer, female</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1008">
							<td>07/08/2024</td>
							<td>CKD</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1009">
							<td>07/08/2024</td>
							<td>Chest wall pain (finding)</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1010">
							<td>07/08/2024</td>
							<td>Multiple joint pain (finding)</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1011">
							<td>07/08/2024</td>
							<td>Pain in axilla (finding)</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1012">
							<td>07/08/2024</td>
							<td>Screening status (finding)</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1013">
							<td>07/08/2024</td>
							<td>Secondary malignant neoplasm of axillary lymph nodes (disorder)</td>						
					</tr>
					<tr ID="EncounterDiagnosisRef-1014">
							<td>07/08/2024</td>
							<td>Vitamin D deficiency (disorder)</td>						
					</tr>
	</tbody>
</table>
</div><h3><a name="id6" href="#toc">Immunizations</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Instructions</th>
				<th>Refusal Reason</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
				<tr><td colspan="7">No data for this encounter</td></tr>
	</tbody>
</table>
</div><h3><a name="id7" href="#toc">Diagnostic Results</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Test</th>
				<th>Units</th>
				<th>Lower Limit</th>
				<th>Upper Limit</th>
				<th>Result</th>
				<th>Flag</th>
				<th>Comments</th>
				<th>Status</th>
				<th>Ordered By</th>
				<th>Specimen Source</th>
				<th>Lab Address</th>
		</tr>
	</thead>
	<tbody>
			<tr><td colspan="13">NONE</td></tr>
	</tbody>
</table>
</div><h3><a name="id8" href="#toc">Medications</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Name</th>
				<th>Route</th>
				<th>Dose</th>
				<th>Frequency</th>
				<th>Instructions</th>
				<th>Start Date</th>
				<th>End Date</th>
				<th>Status</th>
		</tr>
	</thead>
	<tbody>
					<tr ID="MedicationOBS-1015">
							<td/>
							<td>Rosuvastatin Calcium Oral </td>
							<td>orally</td>
							<td>40.0 mg</td>
							<td>daily</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1016">
							<td/>
							<td>Ferrous Sulfate Oral </td>
							<td/>
							<td> </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1017">
							<td/>
							<td>Cyanocobalamin Oral </td>
							<td/>
							<td> </td>
							<td/>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1018">
							<td/>
							<td>Lisinopril Oral </td>
							<td>orally</td>
							<td>30.0 mg</td>
							<td>daily</td>
							<td/>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1019">
							<td/>
							<td>Acetaminophen Oral </td>
							<td>orally</td>
							<td>1.0 capsule</td>
							<td>As Directed</td>
							<td> quantity sufficient for 30 days; 0 refills</td>
							<td/>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1020">
							<td>11/13/2025</td>
							<td>1 ML denosumab 60 MG/ML Prefilled Syringe </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td>once</td>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>11/13/2025</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1021">
							<td>05/15/2025</td>
							<td>1 ML denosumab 60 MG/ML Prefilled Syringe </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td>once</td>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>05/15/2025</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1022">
							<td>11/14/2024</td>
							<td>1 ML denosumab 60 MG/ML Prefilled Syringe </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td>once</td>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>11/14/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1023">
							<td>08/07/2024</td>
							<td>anastrozole 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>08/07/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1024">
							<td>08/07/2024</td>
							<td>ciprofloxacin 500 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every 12 hours</td>
							<td/>
							<td>08/07/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1025">
							<td>05/16/2024</td>
							<td>1 ML denosumab 60 MG/ML Prefilled Syringe </td>
							<td>subcutaneously</td>
							<td>60.0 mg</td>
							<td>once</td>
							<td>Administer SQ injection in the upper arm, upper thigh or abdomen.</td>
							<td>05/16/2024</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1026">
							<td>03/06/2023</td>
							<td>anastrozole 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>03/06/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1027">
							<td>03/03/2023</td>
							<td>anastrozole 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>03/03/2023</td>
							<td/>
							<td>active</td>
					</tr>
					<tr ID="MedicationOBS-1028">
							<td>02/14/2022</td>
							<td>anastrozole 1 MG Oral Tablet </td>
							<td>orally</td>
							<td>1.0 tablet</td>
							<td>every day</td>
							<td/>
							<td>02/14/2022</td>
							<td/>
							<td>active</td>
					</tr>
	</tbody>
</table>
</div><h3><a name="id9" href="#toc">Problems</a></h3><div><table>
	<thead>
		<tr>
							<th>Diagnosis</th>
				<th>Status</th>
				<th>Date of Diagnosis</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="ProblemOBS-1029">
						<td>Anemia</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1030">
						<td>CKD</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1031">
						<td>Multiple joint pain (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1032">
						<td>Secondary malignant neoplasm of axillary lymph nodes (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1033">
						<td>Screening status (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1034">
						<td>Osteoporosis (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1035">
						<td>Long term (current) use of aromatase inhibitors</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1036">
						<td>Recurrent urinary tract infection (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1037">
						<td>Pain in axilla (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1038">
						<td>Chest wall pain (finding)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1039">
						<td>Vitamin D deficiency (disorder)</td>
						<td>Active</td>
						<td/>
				</tr>
				<tr ID="ProblemOBS-1040">
						<td>Breast cancer, female</td>
						<td>Active</td>
						<td/>
				</tr>
	</tbody>
</table>
</div><h3><a name="id10" href="#toc">Vital Signs</a></h3><div><table>
	<thead>
		<tr>
							<th>Date</th>
				<th>Type</th>
				<th>Value</th>
		</tr>
	</thead>
	<tbody>
				<tr ID="VitalSignsRef-1041">
						<td>07/08/2024</td>
						<td>
							Height
							
						</td>
						<td>64.00</td>
				</tr>
				<tr ID="VitalSignsRef-1042">
						<td>07/08/2024</td>
						<td>
							Pain Scale
							
						</td>
						<td>0.00</td>
				</tr>
	</tbody>
</table>
</div><h3><a name="id11" href="#toc">Notes Section</a></h3><div>	<ul><li>
		        Phone - Follow-Up: 
		        <p>
		        		

<br/>
<br/>2911 N. Tenaya Way. <br/>Suite 210<br/>Las Vegas, NV  89128

<br/>
<br/>Phone: (702) 342-1244 Fax: (702) 577-2542



<br/>


<br/>Patient Name: Irmgard Weil

<br/>Date of Birth: 01/07/1938

<br/>Medical Record #: 141218

<br/>Attending Physician: Ammar  Yousif (Hematology/Oncology)

<br/>Location: Las Vegas

<br/>Referring Physician: Agustin, Tricia MD (Internal Medicine)

<br/>


<br/>Phone - Follow-Up

<br/>Date of Visit: 07/08/2024

<br/>


<br/>History of Present Illness

<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>This is an 86 year old lady who initially dx with Rt breast cancer - 2010, when she presented with new calcifications on mammogram . She is s/p Rt Breast biopsy ( 8/2010) - pathology : IDC moderately differentiated , ER-99% positive , PR0%- negative , Her2 neu - negative / SISH . 

<br/>She completed Rt Mastectomy , and SNLD - 9/21/10 - with final pathology : IDC , grade 2 , DCIS present , 1.6 cm , 0/3LN positive , clear margins . Final stage : pT1cN0Mx. 

<br/>No Chemo or RT in adjuvant setting She was started on endocrine therapy - Anastrozole - by Dr Faylona . 5 years completed 2015. 

<br/>Remained well - up to mid 11/2017 --- when she developed Rt axilla palpable lump . 7/7/17 . US guided biopsy Rt axilla - pathology : IDC, Grade2/3, DCIS/LCIS/LVI absent --ER71%- positive , PR-0% , Her2 neu - negative ( 1+) Ki-67- 26%. 

<br/>7/21/17 - PET scan -- Rt axillary tumor - SUV 17 - no distant metastasis . 

<br/>Full axillary dissection was done - 8/15/17 -- 4/12 LN positive metastatic disease, 4 cm , with extra-nodal tumor extension present . Chemo discussed but was not given secondary age. ER positive status - Anastrozole was restarted  11/2017 . . RT completed 11/13/17 ( 6 weeks ). 

<br/>


<br/>She was dx with cervical cancer - 2010- s/p TAH/BSO - no chemo /RT. <br/>

<br/>Interim Hx:<br/> Patient complaining from chronic arthritis. Patient on regular follow-up with nephrology and cardiology. She is off AI for 4 weeks with no improvement in her arthritis <br/>










<br/>Medical History<br/> <ul><li>Anemia</li><li>Breast cancer, female</li><li>CKD</li><li>Chest wall pain (finding)</li><li>Multiple joint pain (finding)</li><li>Pain in axilla (finding)</li><li>Screening status (finding)</li><li>Secondary malignant neoplasm of axillary lymph nodes (disorder)</li><li>Vitamin D deficiency (disorder)</li><li>Osteoporosis (disorder)</li></ul>

<br/>


<br/>Surgical History<br/>    

<br/>


<br/>Medications<br/> Vitamin B-12 (Cyanocobalamin Oral), Lisinopril Oral 30 mg orally daily, Ferrous Sulfate Oral, Anastrozole Oral 1 mg tablet 
1 tablet orally every day.   start 3/14/22 
, Tylenol (Acetaminophen Oral) mg 1 capsule orally As Directed  quantity sufficient for 30 days; 0 refills, Rosuvastatin Calcium Oral 40 mg orally daily

<br/>


<br/>    

<br/>


<br/>Smoking History<br/>


<br/>Smoking Tobacco : Never smoker; Smokeless Tobacco : none found; Vaping : none found

<br/>


<br/>Social History

<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>Alcohol Use: none

<br/>Recreational Drug Use: none

<br/>Marital Status: Divorced 

<br/>Children: 2











<br/>Family History<br/> <ul><li>Father: Deceased</li><li>Mother: Deceased</li><li>Sister 1: Diabetes</li></ul>

<br/>


<br/>Allergies<br/> <ul><li>Sulfamide</li><li>acetazolamide</li><li>codeine</li><li>etodolac</li><li>morphine</li></ul>

<br/>


<br/>Review of Systems

<br/>
<br/>


<br/>Constitutional: Denies fever, weight loss, fatigue

<br/>Eyes: Denies visual changes

<br/>ENT/Mouth: Denies hearing problems, oral problems

<br/>Cardiovascular: Denies chest pain, palpitations

<br/>Respiratory: Denies shortness of breath, cough

<br/>Gastrointestinal: Denies abdominal pain, nausea, vomiting, constipation, diarrhea

<br/>Genitourinary: Denies burning, pain on urination, blood in urine, incontinence

<br/>Musculoskeletal: Denies muscle pain, bone pain, joint pain

<br/>Skin: Denies rashes, itchiness, ulcers

<br/>Neurologic: Denies headaches, dizziness, confusion, seizures, weakness or numbness

<br/>Psychiatric: Denies depression, anxiety

<br/>Hematologic/Lymphatic: Denies other bleeding, bruising, swollen lymph nodes


<br/>


<br/>Laboratory<br/>
<br/>

<br/>
<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>

<br/>


<br/>



<br/>Radiology<br/>
<br/>


<br/>Pathology<br/>
<br/>


<br/>Impression and Recommendations

<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>
<br/>#Rt breast cancer - 8/2010- s/p mastectomy - pT1cN0Mx -- s/p mastectomy - anastrozole only in adjuvant setting - 2010-2015 ( 5 years )<br/>
#Recurrent breast Cancer - Rt axilla - 7/2017 . S/P - Axillary dissection , RT to axilla and restarted Anastrozole - 11/2017 -- Ongoing . 

<br/>At that time 4/12 LN positive for disease , extracapsular extension noted , 4 cm. 

<br/>#Cervical cancer - 2010- s/p TAH/BSO - no chemo /RT in adjuvant setting<br/>
<br/>


<br/>-Mammogram. August 10, 2021: No suspicious microcalcifications, developing masses or architectural distortion.  Stable glandular parenchymal pattern.  Stable superior left breast density.  No adenopathy

<br/>-CAT scan of the chest without contrast October 4, 2021: 3.3 cm distal thoracic aortic aneurysm.  There is some intimal irregularity along the left lateral wall raising concern for possible dissection.  Right mastectomy changes.  Renal atrophy and calcifications are noted.  No evidence of recurrent disease no lymphadenopathy or other abnormalities.

<br/>-Mammo 09/16/2022: Birad 2. Will continue yearly mammogram <br/>
-DEXA scan 9/16/2022: osteopenia. No significant change from prior DEXA scan <br/>-Mammo/US 10/27/2023: BI-RADS Category 2: Benign.
Recommend routine mammographic follow-up<br/>-DEXA scan 07/11/2023: Bone density is osteoporotic. I discussed the results with the patient. I discussed treatment options fosamax, reclast, prolia. Patient declined therapy for now. I discussed Vitamin D/calcium, patient was informed by her nephrologist not to take vitamin D.<br/>
<br/>
<br/>-11/16/2024 I spoke with the patient on the phone today.  Patient reported worsening joint pain/arthritis.  Patient on regular follow-up with nephrologist.  Patient read about osteoporosis and now she is willing to proceed with treatment.  I discussed possible side effect with the patient including Jaw osteonecrosis.  Due to her kidney insufficiency I will order Prolia.<br/>

<br/>Plan:<br/>
-Advised patient to hold anastrozole for another 4 weeks due to worsening joint pain, will consider switching to different AI<br/>-Prolia ordered for osteoporosis, discussed possible side effect with the patient<br/>
-Mammo/US due 10/2024<br/>-Will repeat DEXA scan 10/2024<br/>
-Continue follow up with Nephrology <br/>
-RTC in 4 weeks to assess joint pain <br/>

<br/>


<br/>


<br/>










<br/>Discussion<br/>
<br/>
<br/>
<br/>
<br/>ECOG: N/A


<br/>Depression: N/A

<br/>


<br/>
<br/>
<br/>Visit was conducted by [ PHONE ].

<br/>
<br/>


<br/>Patient agreed to visit by Phone and copay if applicable.<br/>
<br/>[ 5 ] minutes were spent with the patient and more than [ 50% ] of time was spent counselling/coordinating care.




<br/>
<br/>Diagnosis<br/> <ul><li>Anemia</li><li>Breast cancer, female</li><li>CKD</li><li>Chest wall pain (finding)</li><li>Multiple joint pain (finding)</li><li>Pain in axilla (finding)</li><li>Screening status (finding)</li><li>Secondary malignant neoplasm of axillary lymph nodes (disorder)</li><li>Vitamin D deficiency (disorder)</li></ul>

<br/>CC<br/>    <br/>




<br/>


<br/>Signature<br/>
<br/>


<br/>Note created by Ammar Yousif MD, Physician, Hematology/Oncology

<br/>Electronically signed by Ammar Yousif MD 07/08/2024 04:57 PM PDT 
		        </p>
		      </li></ul>
</div><br/><br/></body></html>